1. World Health Organization Resolution on e health.. 58th World Health Assembly, Geneva, Switzerland, 2005. (Ninth plenary meeting, 25 May 2005 — Committee A, seventh report). (cited 2019 May 14). Available from: https://www.who.int/healthacademy/media/WHA58-28-en.pdf

2. Supporting effective deployment of telehealth and mobilehealth.. COCIR telemedicine toolkit. (cited 2019 May 16).Available from: https://www.cocir.org/fileadmin/Publications_2011/telemedicine_toolkit_link2.pdf

3. Владзимирский А. В. Телемедицина. ООО «Цифровая типография», 2011. 437 с.

4. CISCO VNI Mobile Forecast Highlights, 2016–2021.Central and Eastern Europe — 2021 Forecast Highlights. (cited 2019 May 15). Available from: https://www.cisco.com/c/m/en_us/solutions/service-provider/forecast-highlights-mobile.html

5. GSMA Mobile Economy 2018.. Mob Econ 2018. (cited 2019 May 16) Available from: https://www.gsma.com/mobileeconomy/.

6. Cowie MR, Bax J, Bruining N, Cleland JGF, Koehler F, Malik M et al. e Health: a position statement of the European Society of Cardiology. Eur Heart J. 2016;37(1):63–66. doi:10.1093/eurheartj/ehv416

7. Neubeck L, Lowres N, Benjamin EJ, Freedman SB, Coorey G,Redfern J. The mobile revolution — using smartphone apps to prevent cardiovascular disease. Nat Rev Cardiol. 2015;12(6):350–360. doi:10.1038/nrcardio.2015.34

8. Sarwar CMS, Vaduganathan M, Anker SD, Coiro S, Papadimitriou L, Saltz J et al. Mobile health applications in cardio-vascular research. Int J Cardiol. 2018;269:265–271. doi:10.1016/j.ijcard.2018.06.039

9. Dayer LE, Shilling R, Van Valkenburg M, Martin BC,Gubbins PO, Hadden K et al. Assessing the medication adherenceapp marketplace from the health professional and consumervantage points. JMIR MHealth UHealth. 2017;5(4):e45. doi:10.2196/mhealth.6582

10. Diaz JA, Griffith RA, Ng JJ, Reinert SE, Friedmann PD, Moulton AW. Patients’ use of the Internet for medical information. J Gen Intern Med. 2002;17(3):180–185.

11. Глобальная обсерватория ВОЗ по электронному здравоохранению. Том 2. Телемедицина: возможности и положение дел в государствах-членах. Available from: https://apps.who.int/iris/bitstream/handle/10665/44497/9789244564141_rus.pdf;jsessionid=D6B4A4788F623476E6ACD5D9BF164D46?sequence=4

12. Глобальная обсерватория по электронному здраво¬охранению. Том 3. Мобильное здравоохранение: Новые горизонты здравоохранения через технологии мобильной связи.. Available from: https://apps.who.int/iris/bitstream/handle/10665/44607/9789244564257_rus.pdf?sequence=3

13. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ,Dennison Himmelfarb C et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/ PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertens Dallas Tex. 2017. doi:10.1161/HYP.0000000000000066

14. NCD mortality and morbidity. World Health Organization. (cited 2019 May 15). Available from: https://www.who.int/gho/ncd/mortality_morbidity/en/

15. Dorsey ER, Topol EJ. State of Telehealth. N Engl J Med. 2016;375(2):154–161. doi:10.1056/NEJMra1601705

16. Noncommunicable diseases country profiles 2018. Geneva: World Health Organization. 2018. Licence: CC BY-NC-SA 3.0 IGO.

17. Petrukhin IS, Lunina EY. Cardiovascular disease risk factors and mortality in Russia: challenges and barriers. Public Health Rev 2011;33:436–49. doi:10.1007/BF03391645

18. Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D,Chirinos JA et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet. 2016;388(10060):2665–2712. doi:10.1016/S0140-6736(16)31134-5

19. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K et al. Global disparities of hypertension prevalence and control clinical perspective: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134(6):441–450. doi:10.1161/CIRCULATIONAHA.115.018912

20. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. doi:10.1093/eurheartj/ehw106

21. Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM,Castillo RR et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6(7):e736–e743. doi:10.1016/S2214-109X(18)30259-6

22. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT et al. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018;137(2):109–118. doi:10.1161/CIRCULATIONAHA.117.032582

23. Чазова И. Е., Жернакова Ю. В., Ощепкова Е. В, Шальнова С. А., Яровая Е. Б., Конради А. О. и др. Распространенность сердечно-сосудистых факторов риска в Российской популяции пациентов с артериальной гипертонией. Кардиология 2014;54(10):4–12.

24. Бойцов С. А., Баланова Ю. А., Шальнова С. А., Деев А. Д., Артамонова Г. В., Гатагонова Т. М. и др. Артериальная гипертония среди лиц 25–64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014;13(4):4–14. doi:10.15829/1728-8800-2014-4-4-14.

25. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet Lond Engl. 2012;380(9859):2224–2260. doi:10.1016/S0140–6736(12)61766–8

26. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T,Emberson J et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet Lond Engl. 2016;387(10022):957–967. doi:10.1016/S0140-6736(15)01225-8

27. Weaver CG, Clement FM, Campbell NRC, James MT,Klarenbach SW, Hemmelgarn BR et al. Healthcare costs attri-butable to hypertension novelty and significance: Canadian Population-Based Cohort Study. Hypertension. 2015;66:502–508. doi:10.1161/HYPERTENSIONAHA.115.05702

28. eHealth Action Plan 2012–2020: Innovative healthcare for the 21st century.Digit Single Mark. (cited 2019 May 15). Available from: https://ec.europa.eu/digital-single-market/en/news/ehealth-action-plan-2012-2020-innovative-healthcare-21st-century (cited 2019 May 16).

29. Alsabbagh MHDW, Lemstra M, Eurich D, Lix LM, Wilson TW, Watson E et al. Socioeconomic status and nonadhe-rence to antihypertensive drugs: a systematic review and meta-analysis. Value Health. 2014;17(2):288–296. doi:10.1016/j.jval.2013.11.011

30. Adherence to long-term therapies: evidence for action. World Health Organization. 2003. ISBN 92 4 154599 2.

31. Bosworth HB, Granger BB, Mendys P, Brindis R, Burkhol-der R, Czajkowski SM et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412–424. doi:10.1016/j.ahj.2011.06.007

32. Gosmanova EO, Kovesdy CP. Adherence to antihypertensive medications: is prescribing the right pill enough? Nephrol Dial Transplant. 2015;30(10):1649–1656. doi:10.1093/ndt/gfu330

33. Osterberg L, Blaschke T. Adherence to Medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100

34. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F.Relationship of blood pressure control to adherence with antihyper-tensive monotherapy in 13 managed care organizations. JMCP. 2006;12(3):239–245. doi:10.18553/jmcp.2006.12.3.239

35. Hamdidouche I, Jullien V, Boutouyrie P, Billaud E, Azizi M, Laurent S. Drug adherence in hypertension: from methodological issues to cardiovascular outcomes. J Hypertens. 2017;35(6):1133–1144. doi:10.1097/HJH.0000000000001299

36. Perreault S, Dragomir A, White M, Lalonde L, Blais L,Bérard A. Better adherence to antihypertensive agents and risk reduction of chronic heart failure. J Intern Med. 2009;266(2):207–218.

37. Perreault S, Dragomir A, Roy L, White M, Blais L, Lalonde Let al. Adherence level of antihypertensive agents in coronary artery disease. Br J Clin Pharmacol. 2010;69(1):74–84. doi:10.1111/j.1365-2125.2009.03547.x

38. Kettani F Z, Dragomir A, Côté R, Roy L, Bérard A, Blais Let al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke. 2009;40 (1):213–220. doi:10.1161/STROKEAHA.108.522193

39. Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS,Elnour AA. Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(4):e5641. doi:10.1097/MD.0000000000005641

40. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. J Am Med Assoc. 2006;296(21):2563–2571. doi:10.1001/jama.296.21.joc60162

41. Cutrona SL, Choudhry NK, Fischer MA, Servi AD, Stedman M, Liberman JN et al. Targeting cardiovascular medication adherence interventions. J Am Pharm Assoc. 2012;52(3):381–397. doi:10.1331/JAPhA.2012.10211

42. de Jager RL, de Beus E, Beeftink MMA, Sanders MF, Vonken E J, Voskuil M et al. Impact of medication adherence on the effect of renal denervation novelty and significance: The SYMPATHY Trial. Hypertension. 2017;69(4):678–684. doi:10.1161/HYPERTENSIONAHA.116.08818

43. Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens Res. 2011;34(1):87–90. doi:10.1038/hr.2010.183

44. Krzesinski JM, Krzesinski F. Importance of a bad adherence to the antihypertensive treatment in the hypertensive population. How to improve it? Rev Med Liege. 2010;65(5–6):278–284.

45. Souza WKSB de, Jardim PCBV, Porto LB, Araújo FA, Sousa ALL, Salgado CM. Comparison and correlation between self-measured blood pressure, casual blood pressure measurement and ambulatory blood pressure monitoring. Arq Bras Cardiol. 2011;97(2):148–155. doi:10.1590/S0066–782X2011005000076

46. Kesselheim AS, Bykov K, Avorn J, Tong A, Doherty M,Choudhry NK. Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardialinfarction: cohort and nested case-control studies. Ann Intern Med. 2014;161(2):96–103. doi:10.7326/M13-2381

47. Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L,Mann DM. Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation. 2011;123(15):1611–1621. doi:10.1161/CIRCULATIONAHA.110.983874

48. Mancia G, Parodi A, Merlino L, Corrao G. Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class. J Hypertens. 2011;29(5):1012–1018. doi:10.1097/HJH.0b013e32834550d0

49. Bowling A, Rowe G, Lambert N, Waddington M, Mahtani KR, Kenten C et al. The measurement of patients’ expectations for health care: a review and psychometric testing of a measure of patients’ expectations. Health Technol Assess Winch Engl. 2012;16(30):1–509. doi:10.3310/hta16300

50. Jani BD, Blane DN, Mercer SW. The role of empathy in therapy and the physician-patient relationship. Forsch Komplementarmedizin. 2012;19(5):252–257. doi:10.1159/000342998

51. Lebeau J P, Cadwallader J S, Aubin-Auger I, Mercier A,Pasquet T, Rusch E et al. The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review. BMC Fam Pract. 2014;15:130. doi:10.1186/1471-2296-15-130

52. Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ,Wines RCM et al. Interventions to improve adherence to delf-administered medications for chronic diseases in the united states: a systematic review. Ann Intern Med. 2012;157(11):785. doi:10.7326/0003-4819-157-11-201212040-00538

53. Naderi SH, Bestwick JP, Wald DS. Adherence to drugsthat prevent cardiovascular disease: meta-analysis on 376,162patients. Am J Med. 2012;125(9):882–887.e1. doi:10.1016/j.amjmed.2011.12.013

54. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34 (28):2159–219. doi:10.1093/eurheartj/eht151

55. Hill MN, Miller NH, DeGeest S, on Behalf of the American Society of Hypertension Writing Group. ASH Position Paper: Adherence and persistence with taking medication to control high blood pressure. J Clin Hypertens. 2010;12(10):757–764. doi:10.1111/j.1751-7176.2010.00356.x

56. Ayman D, Goldshine A. Blood pressure determination by patients with essential hypertension: I. The difference between clinic and home readings before treatment. Am J Med Sci. 1940:465–474.

57. Горбунов В. М., Смирнова М. И. Как диагностировать скрытую артериальную гипертензию? Учебное пособие для врачей. Нижний Новгород: ДЕКОМ; 2012. 63 c.

58. Kallioinen N, Hill A, Horswill MS, Ward HE, Watson MO.Sources of inaccuracy in the measurement of adult patients’ resting blood pressure in clinical settings: a systematic review. J Hypertens. 2017;35:421–441. doi:10.1097/HJH.0000000000001197

59. Rinfret F, Cloutier L, L’Archevêque H, Gauthier M, Laskine M,Larochelle P et al. The gap between manual and automated office blood pressure measurements results at a hypertension clinic. Can JCardiol. 2017;33(5):653–657. doi:10.1016/j.cjca.2017.01.021

60. Pickering TG, White WB, on behalf of the American Society of Hypertension Writing Group. ASH Position Paper: Home and ambulatory blood pressure monitoring. When and how to use self (Home) and ambulatory blood pressure monitoring. J Clin Hypertens. 2008;10(11):850–855. doi:10.1111/j.1751–7176.2008.00043.x

61. Stergiou G, Argyraki K, Moyssakis I, Mastorantonakis S,Achimastos A, Karamanos V et al. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens. 2007;20(6):616–621. doi:10.1016/j.amjhyper.2006.12.013

62. Kang Y Y, Li Y, Huang Q F, Song J, Shan X L, Dou Y et al. Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension. J Hypertens. 2015;33(8):1580–1587. doi:10.1097/HJH.0000000000000596

63. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983;249(20):2792–2798.

64. Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378(16):1509–1520. doi:10.1056/NEJMoa1712231

65. Hara A, Tanaka K, Ohkubo T, Kondo T, Kikuya M, Metoki H et al. Ambulatory versus home versus clinic blood pressure: the association with subclinical cerebrovascular diseases: The Ohasama Study. Hypertension. 2012;59(1):22–28. doi:10.1161/HYPERTENSIONAHA.111.174938

66. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study. Circulation. 2005;111(14):1777–1783. doi:10.1161/01.CIR.0000160923.04524.5B

67. Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. JASH. 2016;10(3):224–234.e17. doi:10.1016/j.jash.2015.12.013

68. Boubouchairopoulou N, Karpettas N, Athanasakis K, Kollias A, Protogerou AD, Achimastos A et al. Cost estimation of hypertension management based on home blood pressure monitoring alone or combined office and ambulatory blood pressure measurements. JASH. 2014;8(10):732–738. doi:10.1016/j.jash.2014.07.027

69. Kollias A, Andreadis E, Agaliotis G, Kolyvas GN, Achimastos A, Stergiou GS. The optimal night-time home blood pressure monitoring schedule: agreement with ambulatory blood pressure and association with organ damage. J Hypertens. 2018;36 (2):243–249. doi:10.1097/HJH.0000000000001562

70. Nasothimiou EG, Karpettas N, Dafni MG, Stergiou GS.Patients’ preference for ambulatory versus home blood pressure monitoring. J Hum Hypertens. 2014;28(4):224–229. doi:10.1038/jhh.2013.104

71. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressu-re control by home monitoring: meta-analysis of randomised trials. Br Med J. 2004;329(7458):145. doi:10.1136/bmj.38121.684410.AE

72. Agarwal R, Bills JE, Hecht TJW, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57(1):29–38. doi:10.1161/HYPERTEN-SIONAHA.110.160911

73. Fletcher BR, Hartmann-Boyce J, Hinton L, McManus RJ.The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: A Systematic Review and Meta-Analysis. Am J Hypertens. 2015;28(10):1209–1221. doi:10.1093/ajh/hpv008

74. Shahaj O, Denneny D, Schwappach A, Pearce G, Epiphaniou E, Parke HL et al. Supporting self-management for people with hypertension: a meta-review of quantitative and qualitative systematic reviews. J Hypertens. 2018;37(2):264–279. doi:10.1097/HJH.0000000000001867

75. Ntineri A, Kalogeropoulos PG, Kyriakoulis KG, Aissopou EK,Thomopoulou G, Kollias A et al. Prognostic value of average home blood pressure and variability: 19 year follow-up of the Didima study. J Hypertens. 2018;36(1):69–76. doi:10.1097/HJH.0000000000001497

76. Stergiou GS, Siontis KCM, Ioannidis JPA. Home blood pressure as a cardiovascular outcome predictor: it’s time to take this method seriously. Hypertension. 2010;55(6):1301–1303. doi:10.1161/HYPERTENSIONAHA.110.150771

77. Niiranen TJ, Hänninen M R, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertens Dallas Tex. 2010;55(6):1346–1351. doi:10.1161/HYPERTENSIONAHA.109.149336

78. Parati G, Omboni S, Bilo G. Why is out-of-office blood pressure measurement needed? Hypertension. 2009;54(2):181–187. doi:10.1161/HYPERTENSIONAHA.108.122853

79. Parati G, Stergiou G, O’Brien E, Asmar R, Beilin L, Bilo Get al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32(7):1359–1366. doi:10.1097/HJH.0000000000000221

80. O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–1768. doi:10.1097/HJH.0b013e328363e964

81. Недогода С. В., Баранова Е. И., Конради А. О., Арутюнов Г. П., Дупляков Д. В., Козиолова Н. А. и др. Алгоритмы ведения пациента с артериальной гипертензией. Общероссийская общественная организация содействия профилактике и лечению артериальной гипертензии «Антигипертензивная лига». Санкт-Петербург, 2015. Издание первое. [Available from: http://www.ahleague.ru/images/rekom/Algoritmy_AG.pdf

82. Parati G, Omboni S. Role of home blood pressure telemoni-toring in hypertension management: an update. Blood Press Monit. 2010;15(6):285–295. doi:10.1097/MBP.0b013e328340c5e4

83. Stergiou GS, Nasothimiou EG. Hypertension: Does home telemonitoring improve hypertension management? Nat Rev Nephrol. 2011;7(9):493–495. doi:10.1038/nrneph.2011.108

84. Trappenburg JCA, Niesink A, de Weert-van Oene GH,van der Zeijden H, van Snippenburg R, Peters A et al. Effectsof telemonitoring in patients with chronic obstructive pulmonary disease. Telemed J E Health. 2008;14(2):138–146. doi:10.1089/tmj.2007.0037

85. Giordano A, Scalvini S, Zanelli E, Corrà U, Longobardi GL,Ricci VA et al. Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. Int J Cardiol. 2009;131(2):192–199. doi:10.1016/j.ijcard.2007.10.027

86. Cherry JC, Moffatt TP, Rodriguez C, Dryden K. Diabetes disease management program for an indigent population empowered by telemedicine technology. Diabetes Technol Ther. 2002;4(6):783–791. doi:10.1089/152091502321118801

87. Flodgren G, Rachas A, Farmer AJ, Inzitari M, Shepperd S. Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2015;(9): CD002098. doi:10.1002/14651858.CD002098.pub2

88. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31(3):455–467; discussion 467–468. doi:10.1097/HJH.0b013e32835ca8dd

89. Verberk WJ, Kessels AGH, Thien T. Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis. Blood Press Monit. 2011;16(3):149–155. doi:10.1097/MBP.0b013e328346e092

90. Liu S, Dunford SD, Leung YW, Brooks D, Thomas SG,Eysenbach G et al. Reducing blood pressure with Internet-based interventions: a meta-analysis. Can J Cardiol. 2013;29(5):613–621. doi:10.1016/j.cjca.2013.02.007

91. Duan Y, Xie Z, Dong F, Wu Z, Lin Z, Sun N et al. Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies. J Hum Hypertens. 2017;31(7):427–437. doi:10.1038/jhh.2016.99

92. Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P,Burnier M et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3(2):e000718. doi:10.1161/JAHA.113.000718

93. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J et al. Effectiveness of home blood pressure monitoring, Web communication and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299(24):2857–2867. doi:10.1001/jama.299.24.2857

94. Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc Ther. 2015;13(2):209–221. doi:10.1586/14779072.2015.1001368

95. Gallagher H, de Lusignan S, Harris K, Cates C. Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review. Br J Gen Pract. 2010;60(575):e258–e265. doi:10.3399/bjgp10X502164

96. McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376(9736):163–172. doi:10.1016/S0140-6736(10)60964-6

97. McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C,Hodgkinson J et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949–959. doi:10.1016/S0140-6736(18)30309-X

98. Boman K, Brenander A, Gustavsson M, Furberg CD. A pilot test of a new tool for remote blood pressure monitoring. J Telemed Telecare. 2014;20(5):239–241. doi:10.1177/1357633X14536348

99. Ralston JD, Cook AJ, Anderson ML, Catz SL, Fishman PA,Carlson J et al. Home blood pressure monitoring, secure electronic messaging and medication intensification for improving hypertension control: a mediation analysis. Appl Clin Inform. 2014;5(1):232–248. doi:10.4338/ACI-2013-10-RA-0079

100. McKinstry B, Hanley J, Wild S, Pagliari C, Paterson M,Lewis S et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial. BMJ. 2013;346:f3030.

101. Mengden T, Ewald S, Kaufmann S, vor dem Esche J, Uen S,Vetter H. Telemonitoring of blood pressure self measurement in the OLMETEL study. Blood Press Monit. 2004;9(6):321–325.

102. Parati G, Omboni S, Albini F, Piantoni L, Giuliano A, Revera M et al. Home blood pressure telemonitoring improves hypertension control in general practice. The TeleBPCare study. J Hypertens. 2009;27(1):198–203.

103. Kiselev AR, Gridnev VI, Shvartz VA, Posnenkova OM, Dovgalevsky PY. Active ambulatory care management supported by short message services and mobile phone technology in patients with arterial hypertension. JASH. 2012;6(5):346–355. doi:10.1016/j.jash.2012.08.001

104. Widmer RJ, Collins NM, Collins CS, West CP, Lerman LO,Lerman A. Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. Mayo Clin Proc. 2015;90(4):469–480. doi:10.1016/j.mayocp.2014.12.026

105. Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S. Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure. Blood Press. 2018;27(4):185–187. doi:10.1080/08037051.2018.1486178

106. Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J,Torgerson J et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9(4Pt1):285–292.

107. Bobrie G, Postel-Vinay N, Delonca J, Corvol P, SETHIInvestigators. Self-measurement and self-titration in hypertension: a pilot telemedicine study. Am J Hypertens. 2007;20(12):1314–1320. doi:10.1016/j.amjhyper.2007.08.011

108. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Maciosek MV, Nyboer RA et al. A Successful multifaceted trial to improve hypertension control in primary care: why did it work? J Gen Intern Med. 2015;30(11):1665–1672. doi:10.1007/s11606-015-3355-x

109. Kerby TJ, Asche SE, Maciosek MV, O’Connor PJ, Sperl-Hillen JM, Margolis KL. Adherence to blood pressure telemonitoring in a cluster-randomized clinical trial. J Clin Hypertens (Greenwich). 2012;14(10):668–674. doi:10.1111/j.1751–7176.2012.00685.x

110. Morawski K, Ghazinouri R, Krumme A, Lauffenburger JC,Lu Z, Durfee E et al. Association of a smartphone application with medication adherence and blood pressure control: The MedISAFE-BP Randomized Clinical Trial. JAMA Intern Med. 2018;178(6):802–809. doi:10.1001/jamainternmed.2018.0447

111. AbuDagga A, Resnick HE, Alwan M. Impact of blood pressure telemonitoring on hypertension outcomes: a literature review. Telemed J E Health. 2010;16(7):830–838. doi:10.1089/tmj.2010.0015

112. Purcell R, McInnes S, Halcomb EJ. Telemonitoring can assist in managing cardiovascular disease in primary care: a systematic review of systematic reviews. BMC Fam Pract. 2014;15:43. doi:10.1186/1471-2296-15-43

113. Magid DJ, Ho PM, Olson KL, Brand DW, Welch LK, Snow KE et al. A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care. 2011;17(4):e96-e103.

114. Kumar N, Khunger M, Gupta A, Garg N. A content analysis of smartphone-based applications for hypertension management. J Am Soc Hypertens. 2015;9(2):130–136. doi:10.1016/j.jash.2014.12.001

115. de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012;12: CD007459. doi:10.1002/14651858.CD007459.pub2

116. Vodopivec-Jamsek V, de Jongh T, Gurol-Urganci I, Atun R, Car J. Mobile phone messaging for preventive health care. Cochrane Database Syst Rev. 2012;12: CD007457. doi:10.1002/14651858.CD007457.pub2

117. Palmer MJ, Barnard S, Perel P, Free C. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database Syst Rev. 2018;6:CD012675. doi:10.1002/14651858.CD012675.pub2

118. Bashshur R, Shannon GW. History of telemedicine: evolution, context, and transformation. New Rochelle, NY: Mary Ann Liebert. 2009.

119. Einthoven W. Le telecardiogramme. Arch Int Physiol. 1906:132–164.

120. Mengden T, Hernandez Medina RM, Beltran B, Alvarez E,Kraft K, Vetter H. Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens. 1998;11 (12):1413–1417.

121. Parati G, Dolan E, McManus RJ, Omboni S. Home blood pressure telemonitoring in the 21st century. J Clin Hypertens (Greenwich). 2018;20(7):1128–1132. doi:10.1111/jch.13305

122. Mc Kinstry B, Hanley J, Lewis S. Telemonitoring in the management of high blood pressure. Curr Pharm Des. 2015;21 (6):823–827.

123. Wagner S, Buus NH, Jespersen B, Ahrendt P, Bertelsen OW,Toftegaard TS. Measurement adherence in the blood pressure self-measurement room. Telemed J E Health. 2013;19(11):826–833. doi:10.1089/tmj.2013.0032

124. Sedgwick P, Greenwood N. Understanding the Hawthorne effect. Br Med J. 2015;351: h4672.

125. Park MJ, Kim HS, Kim KS. Cellular phone and Internet-based individual intervention on blood pressure and obesity in obese patients with hypertension. Int J Med Inf. 2009;78(10):704–710. doi:10.1016/j.ijmedinf.2009.06.004

126. Earle KA, Istepanian RSH, Zitouni K, Sungoor A, Tang B. Mobile telemonitoring for achieving tighter targets of blood pressure control in patients with complicated diabetes: a pilot study. Diabetes Technol Ther. 2010;12(7):575–579. doi:10.1089/dia.2009.0090

127. Madsen LB, Kirkegaard P, Pedersen EB. Blood pressure control during telemonitoring of home blood pressure. A randomized controlled trial during 6 months. Blood Press. 2008;17(2):78–86. doi:10.1080/08037050801915468

128. Black JT, Romano PS, Sadeghi B, Auerbach AD, Ganiats TG, Greenfield S et al. A remote monitoring and telephone nurse coaching intervention to reduce readmissions among patients with heart failure: study protocol for the Better Effectiveness After Transition — Heart Failure (BEAT-HF) randomized controlled trial. Trials. 2014;15:124. doi:10.1186/1745-6215-15-124

129. Rifkin DE, Abdelmalek JA, Miracle CM, Low C, Barsotti R, Rios P et al. Linking clinic and home: a randomized, controlled clinical effectiveness trial of real-time, wireless blood pressure monitoring for older patients with kidney disease and hypertension. Blood Press Monit. 2013;18 (1):8–15. doi:10.1097/MBP.0b013e32835d126c

130. Neumann CL, Menne J, Rieken EM, Fischer N, Weber MH,Haller H et al. Blood pressure telemonitoring is useful to achieve blood pressure control in inadequately treated patients with arterial hypertension. J Hum Hypertens. 2011;25(12):732–738. doi:10.1038/jhh.2010.119

131. Omboni S, Caserini M, Coronetti C. Telemedicine and M Health in hypertension management: technologies, applications and clinical evidence. High Blood Press Cardiovasc Prev. 2016;23 (3):187–196. doi:10.1007/s40292-016-0143-6

132. Singh K, Drouin K, Newmark LP, Rozenblum R, Lee J, Landman A et al. Developing a framework for evaluating the patient engagement, quality and safety of mobile health applications. Issue Brief (Commonw Fund). 2016;5:1–11. PMID:26934758.

133. Parati G, Torlasco C, Omboni S, Pellegrini D. Smartphone applications for hypertension management: a potential game-changer that needs more control. Curr Hypertens Rep. 2017;19 (6):48. doi:10.1007/s11906-017-0743-0

134. ESH CARE app dedicated app for smartphones and tablets.. European Society of Hypertension website. 2018. (cited 2019 May 14). Available from: https://www.eshonline.org/guidelines/blood-pressure-monitoring/

135. Li JS, Barnett TA, Goodman E, Wasserman RC, Kemper AR,American Heart Association Atherosclerosis, Hypertension and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity and Metabolism. Approaches to the prevention and management of childhood obesity: the role of social networks and the use of social media and related electronic technologies: a scientific statement from the American Heart Association. Circulation. 2013;127(2):260–267. doi:10.1161/CIR.0b013e3182756d8e

136. Brown GC, Brown MM, Sharma S. Value-based medicine: evidence-based medicine and beyond. Ocul Immunol Inflamm. 2003;11(3):157–170. doi:10.1076/ocii.11.3.157.17355

137. Reed SD, Li Y, Oddone EZ, Neary AM, Orr MM, Grubber JMet al. Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension. Am J Hypertens. 2010;23(2):142–148. doi:10.1038/ajh.2009.215

138. Stoddart A, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S et al. Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trial. BMJ Open. 2013;3(5): e002681. doi:10.1136/bmjopen-2013–002681

139. Kaambwa B, Bryan S, Jowett S, Mant J, Bray EP, Hobbs FDR et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol. 2014;21(12):1517–1530. doi:10.1177/2047487313501886

140. Madsen LB, Christiansen T, Kirkegaard P, Pedersen EB.Economic evaluation of home blood pressure telemonitoring: a randomized controlled trial. Blood Press. 2011;20(2):117–125. doi:10.3109/08037051.2010.532306

141. Bondmass M, Bolger N, Castro G, Avitall B. The effect of home monitoring and telemanagement on blood pressure control among African Americans. Telemed J. 2000;6:15–23. doi:10.1089/107830200311815

142. Rogers MA, Small D, Buchan DA, Butch CA, Stewart CM, Krenzer BE et al. Home monitoring service improves mean arterial pressure in patients with essential hypertension. A randomized, controlled trial. Ann Intern Med. 2001;134(11):1024–1032.

143. Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. 2015;17(4):535. doi:10.1007/s11906-015-0535-3

144. Larsson S, Lawyer P, Silverstein MB. From Concept to Reality: Putting Value-Based Health Care into Practice in Sweden n. d.:13.

145. Tuckson RV, Edmunds M, Hodgkins ML. Telehealth. N Engl J Med. 2017;377(16):1585–1592. doi:10.1056/NEJMsr1503323

146. Jones LK, Raphaelson M, Becker A, Kaloides A, Scharf E. MACRA and the future of value-based care. Neurol Clin Pract. 2016;6(5):459–465. doi:10.1212/CPJ.0000000000000296

147. McLean S, Sheikh A, Cresswell K, Nurmatov U, Mukherjee M, Hemmi A et al. The impact of telehealthcare on the quality and safety of care: a systematic overview. PloS One. 2013;8 (8):e71238. doi:10.1371/journal.pone.0071238

148. Dinesen B, Nonnecke B, Lindeman D, Toft E, Kidholm K,Jethwani K et al. Personalized telehealth in the future: A Global Research Agenda. J Med Internet Res. 2016;18(3):e53. doi:10.2196/jmir.5257

149. Totten AM, Womack DM, Eden KB, McDonagh MS, Griffin JC, Grusing S et al. Telehealth: mapping the evidence for patient outcomes from systematic reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). 2016.

150. Chaudhry HJ, Robin LA, Fish EM, Polk DH, Gifford JD.Improving access and mobility the Interstate Medical Licensure Compact. N Engl J Med. 2015;372(17):1581–1583. doi:10.1056/NEJMp1502639

151. Hirono MS. 1778–114th Congress (2015–2016): TELE-MED Act of 2015. https://www.congress.gov/bill/114th-congress/senate-bill/1778 (accessed August 17, 2018).

152. Ионов М. В., Юдина Ю. С., Авдонина Н. Г., Еме¬льянов И. В., Курапеев Д. И., Звартау Н. Э. и др. Пациент-ориентированный подход к оценке эффективности телемо¬ниторирования артериального давления и дистанционного консультирования при артериальной гипертензии: пилотный проект. Артериальная гипертензия. 2018;24(1):15–28. https://doi.org/10.18705/1607-419X 2018-24-1-15-28

153. 50 things we now know about digital health consumers.. Rock Health (cited 2019 May 15). Available from: https://rockhealth.com/reports/digital-health-consumer-adoption-2016/.

154. Communities Struggle to Care for Elderly, Alone at Home.. WSJ. (cited 2019 May 15). Available from: https://www.wsj.com/articles/communities-struggle-to-care-for-elderly-alone-at-home-1443193481.

155. Wood PW, Boulanger P, Padwal RS. Home blood pressure telemonitoring: rationale for use, required elements and barriers to implementation in Canada. Can J Cardiol. 2017;33(5):619–625. doi:10.1016/j.cjca.2016.12.018

156. Россияне с крепким здоровьем заинтересованы в телемедицине.. НАФИ.(cited 2019 May 16) Available from: http://nafi.ru/analytics/rossiyane-s-krepkim-zdorovem-zainteresovany-v-telemeditsine/

157. CVS Health to Partner with Direct-to-Consumer Telehealth Providers to Increase Access to Physician Care.. CVS Health. (cited 2019 May 15). Available from:https://cvshealth.com/newsroom/press-releases/cvs-health-partner-direct-consumer-telehealth-providers-increase-access.

158. Amazon to Acquire PillPack.. Amazon — Press Room. (cited 2019 May 14). Available from: http://phx.corporate-ir.net/phoenix.zhtml?c=176060&p=irol-newsArticle&ID=2356401.

159. Report to Congress. E health and Telemedicine.. U. S. Department of Health and Human Services. 2016. (cited 2019 May 16). Available from: https://aspe.hhs.gov/system/files/pdf/206751/TelemedicineE-HealthReport.pdf

160. More Kaiser Patients Use Virtual Visits.. Dark Daily. (cited 2019 May 14). Available from: https://www.darkdaily.com/kaiser-permanente-announces-that-virtual-visits-with-providers-have-surpassed-face-to-face-appointments-at-meeting-of-nashville-health-care-council-members/.